ℹ️
🇬🇧
Search
Search for people relevant for "PIH"
PIH
Person
Class
Person
Publication
Programmes
Export current view
prof. PharmDr. Tomáš Šimůnek Ph.D.
Academic staff at Faculty of Pharmacy in Hradec Králové
15 classes
162 publications
Classes
class
Molecular Biology
+6
GAF144 |
Faculty of Pharmacy in Hradec Králové
class
Molecular Biology and Genetics
+5
GAF370 |
Faculty of Pharmacy in Hradec Králové
class
Molecular Basis of Pharmacology and Toxicology
+1
GDEFX05 |
Faculty of Pharmacy in Hradec Králové
Load more classes (5)
Publications
publication
Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity
2008 |
Central Library of Charles University
publication
The effects of PIH (Pyridoxal Isonicotinoyl Hydrazone - a Potent Iron Chelator) in rats
2002 |
Publication without faculty affiliation
publication
Cardiac Troponin T Following Repeated Administration of New Iron-Chelating Agent (PIH)
2001 |
Faculty of Pharmacy in Hradec Králové
publication
The effects of repeated Pyridoxal Isonicotinoyl Hydrazone administration on the haematological and biochemical parameters in rabbits
2000 |
Faculty of Pharmacy in Hradec Králové
publication
The Effects of Repeated Administration of Pyridoxal Isonicotinoyl Hydrazone (A New Iron Chelator) on the Cardiovascular System in Rabbits
2000 |
Faculty of Pharmacy in Hradec Králové
publication
Hydrophobicity-enhanced ferritin nanoparticles for efficient encapsulation and targeted delivery of hydrophobic drugs to tumor cells
2023 |
Faculty of Pharmacy in Hradec Králové
publication
Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up
2022 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine
2022 |
Faculty of Pharmacy in Hradec Králové
publication
Structure-Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase II beta Interactions
2021 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo
2021 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
Load more publications (152)
Loading network view...